Manufacturer record
Livin Formulations: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
2 batches manufactured by Livin Formulations (Telangana) were declared Not of Standard Quality between December 2025 and June 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: 1501/25, Azithromycin Oral Suspension IP 100 mg/5ml (exp Jul 2026). SDT&RL, Bhubaneswar (state lab) found it not of standard quality: Content of Azithromycin. Listed in the June 2026 alert.
Records by type
2 records linked to Livin Formulations in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Azithromycin Oral Suspension IP 100 mg/5ml | Batch 1501/25Mfg Aug 2024 · Exp Jul 2026 | Content of AzithromycinOther | SDT&RL, BhubaneswarState lab | Jun 2026 |
| Paracetamol, Phenylephrine Hydrochloride & Chlorpheniramine Maleate Drops SINUS DROPS | Batch 876/26Mfg Apr 2025 · Exp Mar 2027 | The sample received does not conform to manufacturer specification with respect to The test for pH only.pH | CDTL-HyderabadCDSCO lab | Dec 2025 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.